
Federal Health Minister Mark Butler has pledged a “thorough, public” review of the national pharmacy prescribing trial, acknowledging concerns about patient safety and the rapid expansion of pharmacists’ scope of practice across Australia.
During the GP26 conference in Adelaide, Dr. Ramya Raman, the new president of the RACGP, asked Mark Butler if he would support a clinically robust, independent and publicly available evaluation of pharmacy prescribing under the National Women’s Health Trial. The question alone elicited strong applause from the audience, eclipsed only by his “Yes”.
A contested issue
Butler stated that pharmacy prescribing remains a highly contested issue, with state governments moving at different speeds to expand pharmacists’ scope of practice. “It’s changing so quickly,” he said.
Health ministers, he added, have discussed the need for a more coherent framework for regulatory boards when considering such expansions.
Butler acknowledged concerns about pharmacy prescribing, which extend beyond territorial issues to include quality of care, while also recognizing the potential benefits of increased access to care, such as for uncomplicated urinary tract infections on weekends.
The 12-month national trial, covering uncomplicated UTIs and contraception, is essentially a payment arrangement for services already available under state arrangements. Butler reaffirmed his commitment to a thorough, public evaluation.
Medicare Reforms: Prioritizing Complex Patient Care
Butler indicated that reforming Medicare’s GP consultation items, which are currently time-tiered, will be a priority in the coming months, with the MBS Review Advisory Committee’s final report expected before Christmas.
He acknowledged calls from the RACGP and Australian Medical Association to reconsider the structure of consultation rebates to better reflect increasingly complex patient presentations, with Dr. Raman noting that GPs struggle to manage patients with multiple conditions within the standard 15- to 20-minute appointment timeframe.
Butler said the introduction of the level E consultation item has helped patients needing longer appointments, but he recognized concerns about the structure of rebates for other consultations. “I’m up for that,” he said of restructuring existing arrangements.
He noted that the government has prioritized affordability and bulk billing in its first years in office, rather than broader structural reforms. “I think we’re in a position to look for reform,” he added.
Butler recognized that the Medicare Benefits Schedule was designed with a different model of general practice in mind, one that dates back to the 1980s, and identified items such as the menopause health assessment and heart health assessment as worthy of review to ensure they support patient care adequately.
Related Post: Hospitals Adopt Cost Analytics to Streamline Maternity Care
Tackling Rising Out-of-Pocket Costs in Specialist Care
The minister suggested expanding GPs’ scope of practice to address rising out-of-pocket costs charged by non-GP specialists. He noted that such costs have approximately doubled over the past seven years.
According to Butler, about 1.5 million out-of-pocket charges were three to five times the average charged by other specialists, while 220,000 procedures annually attracted charges more than five times the average. “That is difficult to explain,” he said.
Butler mentioned that the government is exploring changes to referral arrangements and ways to increase competition in parts of the specialist sector, noting that “There’s a lot of work that’s preserved to non-GP specialists that GPs could very rightly be doing if they choose to”.
He described the AMA’s submission to the scope-of-practice review as positive and expressed interest in further discussions with the RACGP.
Independent Medicare Rebate Authority: A Budget Challenge
Butler left open the possibility of introducing an independent authority to determine Medicare rebates, though he warned of substantial budget implications. Dr. Raman challenged him over this year’s 2.6% Medicare indexation increase, which she said was below CPI and healthcare inflation.
She argued that general practice is already struggling despite government investments and asked if independent pricing could better reflect the real cost of care. Butler acknowledged the issue but cautioned against expecting an immediate commitment. “That would be a big step,” he said.
He pointed to the introduction of independent pricing arrangements for hospitals and aged care, as well as his willingness to consider a similar model for the NDIS. “We’ve not made a final decision,” he said. “I don’t want to say never,” he added, noting that independent pricing has become more common across health and social care programs.
Butler said he has not yet received final advice from work involving the department and sector representatives. He welcomed further discussion but described independent Medicare pricing as “a very big budget ask.”
Bulk Billing Progress: Accelerating Toward 2030 Goals
Butler also highlighted the government’s progress on bulk billing, stating that rates have increased by six percentage points over the past 12 months. He said the government is progressing faster than expected toward its target of 90% bulk billing by 2030.
The GP26 conference continues in Adelaide until November 22, 2026.